| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1067262160 |
| P356 | DOI | 10.14310/HORM.2002.11190 |
| P698 | PubMed publication ID | 17178701 |
| P2093 | author name string | George Koliakos | |
| Maria Bougoulia | |||
| Athanassios Triantos | |||
| P433 | issue | 4 | |
| P921 | main subject | obesity | Q12174 |
| P304 | page(s) | 259-269 | |
| P577 | publication date | 2006-10-01 | |
| P1433 | published in | Hormones : international journal of endocrinology and metabolism | Q26839920 |
| P1476 | title | Effect of weight loss with or without orlistat treatment on adipocytokines, inflammation, and oxidative markers in obese women | |
| P478 | volume | 5 |
| Q26795529 | Advances in hepatocellular carcinoma: Nonalcoholic steatohepatitis-related hepatocellular carcinoma |
| Q90704914 | Bariatric Surgery and Hepatocellular Carcinoma: a Propensity Score-Matched Analysis |
| Q59296371 | Decreased Serum Hepcidin and Improved Functional Iron Status 6 Months After Restrictive Bariatric Surgery |
| Q46354434 | Differential inflammatory status in rats susceptible or resistant to diet-induced obesity: effects of EPA ethyl ester treatment |
| Q52338665 | Drugs Involved in Dyslipidemia and Obesity Treatment: Focus on Adipose Tissue. |
| Q37334443 | Effect of orlistat alone or in combination with Garcinia cambogia on visceral adiposity index in obese patients. |
| Q43179088 | Effect of orlistat on the total ghrelin and leptin levels in obese patients |
| Q33708384 | Effects of lifestyle measures, antiobesity agents, and bariatric surgery on serological markers of inflammation in obese patients |
| Q43118146 | Effects of weight reduction on serum vaspin concentrations in obese subjects: modification by insulin resistance |
| Q37921394 | Endothelial dysfunction associated with obesity and the effect of weight loss interventions |
| Q34684200 | F2-isoprostanes as an indicator and risk factor for coronary heart disease |
| Q41506217 | Hepatocellular Carcinoma in the Setting of Non-cirrhotic Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome: US Experience |
| Q36806635 | Improvement of plasma adiponectin, leptin and C-reactive protein concentrations by orlistat: a systematic review and meta-analysis |
| Q37544889 | Inflammatory disease processes and interactions with nutrition |
| Q37296446 | Iron biology, immunology, aging, and obesity: four fields connected by the small peptide hormone hepcidin |
| Q37309148 | Management of obesity in the elderly: too much and too late? |
| Q36842558 | Metabolically favorable remodeling of human adipose tissue by human adenovirus type 36. |
| Q37352219 | Obesity and inflammation: the effects of weight loss |
| Q37469981 | Obesity, inflammation, and liver cancer |
| Q39810394 | Orlistat improves psychomotor performance in humans |
| Q26783372 | Pathogenesis of hepatocarcinogenesis in non-cirrhotic nonalcoholic fatty liver disease: Potential mechanistic pathways |
| Q34576535 | Pharmacological and non-pharmacological interventions to influence adipose tissue function. |
| Q92443452 | Phenolic Compounds and the Anti-Atherogenic Effect of Bee Bread in High-Fat Diet-Induced Obese Rats |
| Q55279804 | Strategies to decrease oxidative stress biomarker levels in human medical conditions: A meta-analysis on 8-iso-prostaglandin F2α. |
Search more.